Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. 

Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.

Life Sciences

Isomorphic Labs

Demis Hassabis

Sergei Yakneen

Pamela Carroll

Miles Congreve

Max Jaderberg

Beverley Mallon

The Leadership Team at Isomorphic Labs is responsible for guiding the company's strategic direction and ensuring the successful integration of AI-first approaches into drug discovery processes. This team, composed of top executives and principal scientists, collaborates to drive innovation, oversee scientific research, manage technological advancements, ensure information security, and foster a dynamic organizational culture. Their combined expertise establishes the framework to achieve breakthroughs in digital biology that will revolutionize medical research and treatment.

Leadership Team

Research and Development

Engineering Team

Leadership Team

About

Team members

Other teams at Isomorphic Labs

Research and Development

Engineering Team